By Sneha S K April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse ...

PHILADELPHIA (WPVI) -- The FDA is investigating an alarming finding on a promising cancer therapy invented at Penn Medicine. It's being linked to rare, secondary cancers. The agency said it received ...

Olivia is a therapy dog at DoveLewis Veterinary Emergency & Specialty Hospital in Portland, Oregon Kelli Bender is the Pets Editor at PEOPLE. She has been working at PEOPLE since 2013, covering pets, ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. In April 2012, a seven-year-old with acute lymphoblastic ...

The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database. The Food and Drug Administration (FDA) has approved the ...

Given the remarkable advances seen with gene therapies for sickle cell disease (SCD), it may seem counterintuitive to suggest the space may be in need of more therapies that have already been ...

Patients with heart failure tended to have lower treatment intensity at hospital admission, but their cardiac load improved as blood pressure treatment intensified. Intensification of blood ...

Share on Pinterest Researchers found that adding statin therapy may lower venous thromboembolism risk in women taking menopausal hormone therapy. Studio Firma/Stocksy Hormone therapy is used to help ...

NEW YORK (Reuters Health) - Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, a large U.S. study suggests. Analyzing data on more than 154,000 older ...

April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse in patients ...